21 May 2013
Keywords: CSL Biotherapies, USA, Government contract, Flu vaccines, Contract
Article | 11 September 2012
CSL Biotherapies, a US subsidiary of Australia’s CSL (ASX: CSL), one of the world's leading manufacturers of influenza ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 September 2012
20 May 2013
© 2013 thepharmaletter.com